# Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD

> **NCT07737054** · EARLY_PHASE1 · RECRUITING · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 13 (estimated)

## Conditions studied

- Post-Traumatic Stress Disorder, PTSD

## Interventions

- **DRUG:** Psilocybin (drug)
- **BEHAVIORAL:** Trauma-Focused Psychotherapy

## Key facts

- **NCT ID:** NCT07737054
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-22
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737054, "Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07737054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*